Transforming growth factor-beta inhibits interferon-gamma-induced HLA-DR expression by cultured human fibroblasts

International Journal of Biochemistry and Cell Biology

Volumn 28, Issue 10, 1996, Pages 1107-1116

  Armendariz Borunda, Juan ^a   Endres, Robert O ^b   Ballou, Leslie R ^b,c   Postlethwaite, Arnold E ^c  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Fibroblast HLA DR; Growth factor beta; Interferon gamma; Prostaglandin; Transforming

Indexed keywords

CYCLIC AMP; GAMMA INTERFERON; HLA DR ANTIGEN; MESSENGER RNA; PROSTAGLANDIN DERIVATIVE; RECOMBINANT GAMMA INTERFERON; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL CYCLE; CONTROLLED STUDY; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; NORMAL HUMAN; SKIN FIBROBLAST;

EID: 0030272808     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/1357-2725(96)00067-2     Document Type: Article

References (40)

1. Alvaro-Gracia J. M., Zvaifler N. J. and Firestein G. S. (1990) Cytokines in chronic inflammatory arthritis. V. Mutual antagonism between interferon-gamma and tumor necrosis factor-alpha on HLA-DR expression, proliferation, collagenase production, and granulocyte macrophage colony-stimulating factor production by rheumatoid arthritis synoviocytes. J. Clin. Invest. 86, 1790-1798.
2. Amaldi I., Reith W., Berte C. and Mach B. (1989) Induction of HLA class II genes by IFN-gamma is transcriptional and requires a transacting protein. J. Immunol. 142, 999-1004.
3. Armendariz-Borunda J., Katai H., Jones C. M., Seyer J. M., Kang A. H. and Raghow R. (1993) Transforming growth factor B is transiently enhanced at a critical stage during liver regeneration following CC14 treatment. Lab. Invest. 69, 283-294.
4. Armendariz-Borunda J., Katayama K. and Seyer J. M. (1992) Transcriptional mechanisms of type I collagen gene expression are differentially regulated by IL-1b, TNFa and TGFb in Ito cells. J. Biol. Chem. 267, 14316-14321.
5. Ballou L. R., Barker S. C., Postlethwaite A. E. and Kang A. H. (1990) Sphingosine potentiates IL-1-mediated prostaglandin E2 production in human fibroblasts. J. Immunol. 145, 4245-4251.
6. Blanar M. A., Boettger E. C. and Flavell R. A. (1988) Transcriptional activation of HLA-DR alpha by interferon gamma requires a transacting protein. Proc. Natl Acad. Sci. USA 85, 4672-4676.
7. Celada A. and Schreiber R. D. (1987) Internalization and degradation of receptor-bound interferon-gamma by murine macrophages. Demonstration of receptor recycling. J. Immunol. 139, 147-153.
8. Collins T., Korman A. J., Wake C. T., Boss J. M., Kappes D. J., Fiers W., Ault K. A., Gimbrone M. A. Jr., Strominger J. L. and Pober J. S. (1984) Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts. Proc. Natl Acad. Sci. USA 81, 4917-4921.
9. Collins T., Lapierre L. A., Fiers W., Strominger J. L. and Pober J. S. (1986) Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A,B antigens in vascular endothelial cells and dermal fibroblasts in vitro. Proc. Natl Acad. Sci. USA 83, 446-450.
10. Czarniecki C. W., Chiu H. H., Wong G. H., McCabe S. M. and Palladino M. A. (1988) Transforming growth factor-beta 1 modulates the expression of class II histocompatibility antigens on human cells. J. Immunol. 140, 4217-4223.
11. Ding A., Nathan C. F., Graycar J., Derynck R., Stuehr D. J. and Srimal S. (1990) Macrophage deactivating factor and transforming growth factors-beta 1 -beta 2 and -beta 3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-gamma. J. Immunol. 145, 940-944.
12. Endres R. O. and Kang A. H. (1988) Induction of Ia antigens on nonlymphoid cells by lymphokines. In Genetic Basis of Autoimmune Disease (Edited by Cruse J. M. and Lewis R. E. Jr), pp. 57-79. Karger, Basel.
13. Espevik T., Figari I. S., Ranges G. E. and Palladino M. J. (1988) Transforming growth factor-beta 1 (TGF-beta 1) and recombinant human tumor necrosis factor-alpha reciprocally regulate the generation of lymphokine-activated killer cell activity. Comparison between natural porcine platelet-derived TGF-beta 1 and TGF-beta 2, and recombinant human TGF-beta 1. J. Immunol. 140, 2312-2316.
14. Feldman M., Londei M., Kissonerghis M., Portillo G., Leech Z., Ziegler A. and Grubeck-Loebenstein B. (1988) Regulation of HLA class II expression and the pathogenesis of autoimmunity. In Genetic Basis of Autoimmune Diseases (Edited by Cruse J. M. and Lewis R. E. Jr), pp. 44-56. Karger, Basel.
15. Filgueira L., Groscurth P. and Aguet M. (1989) Binding and internalization of gold-labeled IFN-gamma by human Raji cells. J. Immunol. 142, 3436-3439.
16. Geppert T. D. and Lipsky P. E. (1985) Antigen presentation by interferon-g-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression. J. Immunol. 135, 3750.
17. Gupta S. L., Sharma G., Caplen H. S., Pyati P. and Burnett P. M. (1989) Involvement of an inducible factor in interferon-gamma-mediated accumulation of HLA gene transcripts. J. Interferon Res. 9, 531-542.
18. Hanaumi K., Gray P. and Suzuki T. (1984) Fcγ receptor-mediated suppression of γ-interferon-induced Ia antigen expression on a murine macrophage-like cell line (P388D1). J. Immunol. 133, 2852-2856.
19. Hong L. L., Johannsen L. and Krueger J. M. (1991) Modulation of human leukocyte antigen DR expression in glioblastoma cells by interferon gamma and other cytokines. J. Neuroimmunol. 35, 139-152.
20. Johnson W. J., Kelley A., Connor J. R., Dalton B. J. and Meunier P. C. (1989) Inhibition of IFN-gamma-induced Ia antigen expression on synovial fibroblasts by IL-1. J. Immunol. 143, 1614-1618.
21. Kehrl J. H., Roberts A. B., Wakefield L. M., Jakowlew S., Sporn M. B. and Fauci A. S. (1986a) Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes. J. Immunol. 137, 3855-3860.
22. Kehrl J. H., Wakefield L. M., Roberts A. B., Jakowlew S., Alvarez M. M., Derynck R., Sporn M. B. and Fauci A. S. (1986b) Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J. Expl Med. 163, 1037-1050.
23. Kuhlman P., Moy V. T., Lollo B. A. and Brian A. A, (1991) The accessory function of murine intercellular adhesion molecule-1 in T lymphocyte activation. Contributions of adhesion and co-activation. J. Immunol. 146, 1773-1782.
24. Lampson L. A. and Levy R. (1980) Two populations of Ia-like molecules on a human B cell line. J. Immunol. 125, 293-299.
25. Ling P. D., Warren M. K. and Vogel S. N. (1985) Antagonistic effect of interferon-β on the interferon-γ-induced expression of Ia antigen in murine macrophages. J. Immunol. 135, 1857-1863.
26. Maurer D. H., Hanke J. H., Mickelson E., Rich R. R. and Pollack M. S. (1987) Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts. J. Immunol. 139, 715-723.
27. Mule J. J. (1988) Transforming growth factor-beta inhibits the in vitro generation of lymphokine-activated killer cells and cytotoxic T cells. Cancer Immunol. Immunother. 26, 95-100.
28. Nezu N., Ryu K., Koide Y. and Yoshida T. O. (1990) Regulation of HLA class II molecule expressions by IFN-γ. The signal transduction mechanism in glioblastoma cell lines. J. Immunol. 145, 3126-3135.
29. Pober J. S., Collins T., Gibrone M. A. Jr., Cotran R. S., Gitlin J. D., Fiers W., Clayberger C., Krensky A. M., Burakoff S. J. and Reiss C. S. (1983) Lymphocytes recognize human endothelial and dermal fibroblast Ia antigens induced by recombinant immune interferon. Nature 305, 726.
30. Rook A. H., Kehrl J. H., Wakefield L. M., Roberts A. B., Sporn M. B., Burlington D. B., Lane H. C. and Fauci A. S. (1986) Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. J. Immunol. 136, 3916-3925.
31. Schindler C., Shuai K., Prezioso V. R. and Darnell J. E. Jr. (1992) Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science 257, 809-815.
32. Steeg P. S., Johnson H. M. and Oppenheim J. J. (1982) Regulation of murine macrophage Ia antigen expression by an immune interferon-like lymphokine: inhibitory effect of endotoxin. J. Immunol. 129, 2402-2406.
33. Tokuda N., Mano T. and Levy R. B. (1990) 1,25-Dihydroxyvitamin D3 antagonizes interferon-gamma-induced expression of class II major histocompatibility antigens on thyroid follicular and testicular Leydig cells. Endocrinology 127, 1419-1427.
34. Tsunawaki S., Sporn M., Ding A. and Nathan C. (1988) Deactivation of macrophages by transforming growth factor-beta. Nature 334, 260-262.
35. Umetsu D. T., Katzen D., Jabara H. H. and Geha R. S. (1986) Antigen presentation by human dermal fibroblasts: activation of resting T lymphocytes. J. Immunol. 136, 440-445.
36. Warren M. K. and Vogel S. N. (1985) Opposing effects of glucocorticoids on interferon-γ-induced murine macrophage Fc receptor and Ia antigen expression. J. Immunol. 134, 2462-2469.
37. Weetman A. P. (1988) Aberrant class II antigen expression and autoimmunity. In Genetic Basis of Autoimmune Disease (Edited by Cruse J. M. and Lewis R. E. Jr), pp. 21-43. Karger, Basel.
38. Woodward J. G., Omer K. W. and Stuart P. M. (1989) MHC class II transcription in different mouse cell types. Differential requirement for protein synthesis between B cells and macrophages. J. Immunol. 142, 4062-4069.
39. Zielinska J. J., Inglot A. D., Inglot O. and Popik W. (1991) Transforming growth factor-beta inhibits the antiviral action of interferons in human embryonic fibroblasts. J. Interferon Res. 11, 87-89.
40. Zuber P., Kuppner M. C. and De Tribolet N. (1988) Transforming growth factor-beta 2 down-regulates HLA-DR antigen expression on human malignant glioma cells. Eur. J. Immunol. 18, 1623-1626.